CLINICAL_TRIALS
trial_result
· 2026-06-29
Clinical Trial Results: Instylla HES Hypervascular Tumor Pivotal Study [NA]
Summary
Pivotal study results for Instylla HES in hypervascular tumors have been completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Instylla, Inc. | Conditions: Hypervascular Tumors | NA | Status: COMPLETED | Results posted: 2026-06-29